U.S. EPA on the Registration Reviews: Draft Human Health and/or Ecological Risk Assessments for on lambda-cyhalothrin and gamma-cyhalothrin.

Written By Michael Leary

December 13, 2017. Comments to the U.S. EPA on the Registration Reviews: Draft Human Health and/or Ecological Risk Assessments for on lambda-cyhalothrin and gamma-cyhalothrin.
Read the comments.

Michael Leary
Previous

Office of the United States Trade Representative on 2018 Special 301 Review: Identification of Countries Under Section 182 of the Trade Act of 1974
Next

European Commission WTO TBT notification G/TBT/N/EU/521 proposal to reclassify propiconazole